Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1884 2
1894 1
1900 2
1901 2
1902 1
1903 1
1905 1
1906 1
1908 1
1955 1
1961 1
1963 3
1964 5
1965 4
1966 2
1967 2
1968 3
1969 1
1970 4
1971 2
1972 3
1973 3
1974 1
1976 1
1978 1
1979 2
1980 2
1981 1
1982 2
1983 4
1984 1
1985 2
1986 2
1987 1
1988 3
1989 3
1990 4
1991 1
1992 4
1993 3
1994 3
1995 3
1996 5
1997 6
1998 10
1999 14
2000 10
2001 11
2002 12
2003 15
2004 19
2005 6
2006 10
2007 7
2008 6
2009 8
2010 12
2011 13
2012 13
2013 13
2014 8
2015 13
2016 10
2017 17
2018 13
2019 12
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

334 results
Results by year
Filters applied: . Clear all
Page 1
Estimating Time to ESRD in Children With CKD.
Furth SL, Pierce C, Hui WF, White CA, Wong CS, Schaefer F, Wühl E, Abraham AG, Warady BA; Chronic Kidney Disease in Children (CKiD); Effect of Strict Blood Pressure Control and ACE Inhibition on the Progression of CRF in Pediatric Patients (ESCAPE) Study Investigators. Furth SL, et al. Among authors: White CA. Am J Kidney Dis. 2018 Jun;71(6):783-792. doi: 10.1053/j.ajkd.2017.12.011. Epub 2018 Apr 10. Am J Kidney Dis. 2018. PMID: 29653769 Free PMC article. Clinical Trial.
Structures of BCL-2 in complex with venetoclax reveal the molecular basis of resistance mutations.
Birkinshaw RW, Gong JN, Luo CS, Lio D, White CA, Anderson MA, Blombery P, Lessene G, Majewski IJ, Thijssen R, Roberts AW, Huang DCS, Colman PM, Czabotar PE. Birkinshaw RW, et al. Among authors: White CA. Nat Commun. 2019 Jun 3;10(1):2385. doi: 10.1038/s41467-019-10363-1. Nat Commun. 2019. PMID: 31160589 Free PMC article.
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
McLaughlin P, Grillo-López AJ, Link BK, Levy R, Czuczman MS, Williams ME, Heyman MR, Bence-Bruckler I, White CA, Cabanillas F, Jain V, Ho AD, Lister J, Wey K, Shen D, Dallaire BK. McLaughlin P, et al. Among authors: White CA. J Clin Oncol. 1998 Aug;16(8):2825-33. doi: 10.1200/JCO.1998.16.8.2825. J Clin Oncol. 1998. PMID: 9704735 Clinical Trial.
Diagnostic and Therapeutic Challenges.
White CA, Suelves AM, Johnson B, Moorthy RS. White CA, et al. Retina. 2019 May;39(5):1027-1030. doi: 10.1097/IAE.0000000000002135. Retina. 2019. PMID: 29489564 No abstract available.
Serum BTP concentrations are not affected by hepatic dysfunction.
Chakraborty D, Akbari A, Knoll GA, Flemming JA, Lowe C, Akbari S, White CA. Chakraborty D, et al. Among authors: White CA. BMC Nephrol. 2018 Apr 13;19(1):87. doi: 10.1186/s12882-018-0881-x. BMC Nephrol. 2018. PMID: 29653513 Free PMC article.
Genome-wide characterization of the routes to pluripotency.
Hussein SM, Puri MC, Tonge PD, Benevento M, Corso AJ, Clancy JL, Mosbergen R, Li M, Lee DS, Cloonan N, Wood DL, Munoz J, Middleton R, Korn O, Patel HR, White CA, Shin JY, Gauthier ME, Lê Cao KA, Kim JI, Mar JC, Shakiba N, Ritchie W, Rasko JE, Grimmond SM, Zandstra PW, Wells CA, Preiss T, Seo JS, Heck AJ, Rogers IM, Nagy A. Hussein SM, et al. Among authors: White CA. Nature. 2014 Dec 11;516(7530):198-206. doi: 10.1038/nature14046. Nature. 2014. PMID: 25503233
Rituximab.
Multani P, White CA. Multani P, et al. Among authors: White CA. Cancer Chemother Biol Response Modif. 2003;21:235-58. Cancer Chemother Biol Response Modif. 2003. PMID: 15338748 Review. No abstract available.
Impaired Phosphate Tolerance Revealed With an Acute Oral Challenge.
Turner ME, White CA, Hopman WM, Ward EC, Jeronimo PS, Adams MA, Holden RM. Turner ME, et al. Among authors: White CA. J Bone Miner Res. 2018 Jan;33(1):113-122. doi: 10.1002/jbmr.3294. Epub 2017 Oct 19. J Bone Miner Res. 2018. PMID: 28914962 Free article.
334 results
Jump to page
Feedback